Bio-Rad Laboratories

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO.B and other ETFs, options, and stocks.

About BIO.B

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments.

CEO

Norman D. Schwartz

CEONorman D. Schwartz

Employees

7,700

Employees7,700

Headquarters

Hercules, California

HeadquartersHercules, California

Founded

1952

Founded1952

Employees

7,700

Employees7,700

BIO.B Key Statistics

Market cap

8.44B

Market cap8.44B

Price-Earnings ratio

-12.87

Price-Earnings ratio-12.87

Dividend yield

—

Dividend yield—

Average volume

4.40

Average volume4.40

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$359.22

52 Week high$359.22

52 Week low

$225.29

52 Week low$225.29

Stock Snapshot

Bio-Rad Laboratories(BIO.B) stock is priced at $312.75, giving the company a market capitalization of 8.44B. It carries a P/E multiple of -12.87.

On 2026-01-21, Bio-Rad Laboratories(BIO.B) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Bio-Rad Laboratories(BIO.B) stock has reached 0, versus its average volume of 4.4.

The stock's 52-week range extends from a low of $225.29 to a high of $359.22.

BIO.B News

Nasdaq 7h

Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now

Bio-Rad Laboratories, Inc. BIO is well-poised to grow in the upcoming quarters, given the demand for its quality control and immunology products in Clinical Dia...

Analyst ratings

57%

of 7 ratings

Buy

42.9%

Hold

57.1%

Sell

People also own

Based on the portfolios of people who own BIO.B. This list is generated using Robinhood data, and it’s not a recommendation.

Thermo Fisher Scientific